Compare CTLP & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTLP | INMD |
|---|---|---|
| Founded | 1992 | 2008 |
| Country | United States | Israel |
| Employees | 345 | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 757.1M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | CTLP | INMD |
|---|---|---|
| Price | $10.36 | $13.58 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 6 |
| Target Price | N/A | ★ $16.75 |
| AVG Volume (30 Days) | ★ 1.3M | 818.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $16.11 | $1.70 |
| Revenue Next Year | $14.37 | $3.99 |
| P/E Ratio | $13.69 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.01 | $12.72 |
| 52 Week High | $11.16 | $19.09 |
| Indicator | CTLP | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 45.21 |
| Support Level | $10.10 | $13.28 |
| Resistance Level | $10.77 | $14.80 |
| Average True Range (ATR) | 0.22 | 0.28 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 41.73 | 58.85 |
Cantaloupe Inc is a technology leader powering self-service commerce by offering one integrated solution for payments processing, logistics, and back-office management. The group offers a comprehensive suite of solutions, including micro-payment processing, self-checkout kiosks, mobile ordering, connected point-of-sale (POS) systems, and enterprise cloud software. Its product and services portfolio consists of Card Readers, Self-Service Kiosks, Smart Coolers, Seed Pick Easy, Cantaloupe Go, Cheq, Smart Lock Connect, and Vine Digital Studio. The company derives revenue streams from subscriptions, transaction processing, and equipment sales.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.